Charles River Laboratories - Company Profile

Charles River Labs offers drug discovery and preclinical development services to pharma and biotech companies. Their services span the entire drug discovery pathway namely target discovery and validation, hit finding, medicinal chemistry, in vivo and in-vitro pharmacology, biomarker development, and IND-enabling studies for both small molecules and biologics. They cater to therapeutic areas such as Oncology, CNS/pain, Inflammation, Immunology, Cardiovascular, Metabolic, Respiratory, Rare and neglected diseases, and others. In 2020, the company recorded annual revenues of $2.9 B and a net profit of $364.3 M.